1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Orthobiologics Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Global Orthobiologics Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.1.1. Demineralized Bone Matrix (DBM)
5.2.1.2. Allograft
5.2.1.3. Bone Morphogenetic Protein (BMP)
5.2.1.4. Viscosupplementation Products
5.2.1.5. Synthetic Bone Substitutes
5.2.1.6. Others
5.2.2. By Application
5.2.2.1. Osteoarthritis & Degenerative Arthritis
5.2.2.2. Spinal Fusion
5.2.2.3. Fracture Recovery
5.2.2.4. Soft Tissue Injuries
5.2.2.5. Maxillofacial & Dental Applications
5.2.3. By End User
5.2.3.1. Hospitals & Ambulatory Centers
5.2.3.2. Research & Academic Institute
5.2.3.3. Dental Clinics
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. The Asia Pacific
5.2.4.4. Latin America
5.2.4.5. The Middle East and Africa
6. North America Orthobiologics Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Type
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.2.5.1. United States
6.2.5.2. Canada
7. Europe Orthobiologics Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Type
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.2.5.1. Germany
7.2.5.2. United Kingdom
7.2.5.3. Italy
7.2.5.4. France
7.2.5.5. Spain
7.2.5.6. Rest of Europe
8. The Asia Pacific Orthobiologics Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Type
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.2.5.1. China
8.2.5.2. India
8.2.5.3. Japan
8.2.5.4. South Korea
8.2.5.5. Rest of Asia Pacific
9. Latin America Orthobiologics Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Type
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.2.5.1. Brazil
9.2.5.2. Mexico
9.2.5.3. Rest of Latin America
10. The Middle East & Africa Orthobiologics Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.3. By Product
10.4. By Type
10.5. By Application
10.5.1. By End User
10.5.2. By Country
10.5.2.1. Saudi Arabia
10.5.2.2. UAE
10.5.2.3. South Africa
10.5.2.4. Rest of Middle East & Africa
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Market Share Analysis, 2021
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Development (Merger, Acquisition, Partnership.)
12. Impact of Covid-19 on Global Orthobiologics Market Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
13.1. Arthrex Inc.
13.2. Seaspine Holdings Corporation
13.3. Sanofi
13.4. Bone Support
13.5. DePuy Synthes
13.6. Integra Lifesciences
13.7. Globus Medical Inc.
13.8. NuVasive Inc.
13.9. Terumo Corporation
13.10. Medtronic PLC
13.11. Stryker Corporation
13.12. Zimmer Biomet
13.13. Pioneer Surgical Technology
13.14. Smith & Nephew plc
13.15. Bioventus LLC
13.16. Orthofix, Inc.
13.17. Genzyme
13.18. Bone Biologics, Corp.
13.19. Osiris Therapeutics, Inc.
13.20. Other prominent players
14. Key Strategic Recommendations
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable